

Bayer
Organization CompanyBayer AG: Pharma & Agrochemical giant facing legal battles, pricing pressures, and investor shifts.
Mentions:4
7 Days:0
About
Bayer AG, a German multinational pharmaceutical and agricultural biotechnology company, is currently facing scrutiny and challenges across various fronts. Recent news highlights legal battles surrounding its Roundup weedkiller, with the Supreme Court hearing an appeal to block thousands of lawsuits. The company's CEO met with the EPA regarding this litigation. Furthermore, Bayer is advocating for higher drug prices in Europe, aligning with US interests, which is meeting resistance. An activist investor has exited their position in Bayer, causing a drop in the company's stock price. The company's historical context is also relevant, as exemplified by the Goethe University occupying the former IG-Farben-Haus, a building with a complex and controversial past. These events underscore Bayer's ongoing navigation of legal, economic, and historical complexities.
Last updated: June 28, 2026
Recent Coverage


US supreme court blocks thousands of lawsuits over Roundup maker’s pesticide warning labels
Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller

MAHA moms test their influence in US glyphosate fight

Can India’s rice farmers reap from US$30 million Amazon carbon credit deal?

US supreme court to hear case that could weaken consumers’ ability to sue for failure to warn of product risks

Stakes high as supreme court set to rule on law involving Monsanto’s weed-killing pesticide

FC Bayern München: Jamal Musiala zeigt, dass er mit zur WM muss – egal, in welcher Form

Starke Pharmasparte: Wie Bayer die nächste Patentklippe umschiffen will
